BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8963031)

  • 1. Anti-peptide monoclonal antibodies to intestinal mucin 3.
    Apostolopoulos V; Xing PX; McKenzie IF
    J Gastroenterol Hepatol; 1995; 10(5):555-61. PubMed ID: 8963031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second-generation monoclonal antibodies to intestinal MUC2 peptide reactive with colon cancer.
    Xing PX; Prenzoska J; Layton GT; Devine PL; McKenzie IF
    J Natl Cancer Inst; 1992 May; 84(9):699-703. PubMed ID: 1569603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies reacting with the MUC2 mucin core protein.
    Devine PL; McGuckin MA; Birrell GW; Whitehead RH; Sachdev GP; Shield P; Ward BG
    Br J Cancer; 1993 Jun; 67(6):1182-8. PubMed ID: 8512804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity of mucin gene expression in normal and neoplastic tissues.
    Ho SB; Niehans GA; Lyftogt C; Yan PS; Cherwitz DL; Gum ET; Dahiya R; Kim YS
    Cancer Res; 1993 Feb; 53(3):641-51. PubMed ID: 7678777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of monoclonal antibodies recognising the peptide core of MUC2 intestinal mucin.
    Durrant LG; Jacobs E; Price MR
    Eur J Cancer; 1994; 30A(3):355-63. PubMed ID: 8204359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second generation anti-MUC1 peptide monoclonal antibodies.
    Xing PX; Prenzoska J; Quelch K; McKenzie IF
    Cancer Res; 1992 Apr; 52(8):2310-7. PubMed ID: 1373108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide epitopes in breast cancer mucins.
    Xing PX; Apostolopoulos V; Trapani J; Prenzoska J; McKenzie IF
    Adv Exp Med Biol; 1994; 353():9-16. PubMed ID: 7527180
    [No Abstract]   [Full Text] [Related]  

  • 8. Discrimination of MUC1 mucins from other sialyl-Le(a)-carrying glycoproteins produced by colon carcinoma cells using a novel monoclonal antibody.
    Baeckström D; Nilsson O; Price MR; Lindholm L; Hansson GC
    Cancer Res; 1993 Feb; 53(4):755-61. PubMed ID: 7679050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral immunity against a tandem repeat epitope of human mucin MUC-1 in sera from breast, pancreatic, and colon cancer patients.
    Kotera Y; Fontenot JD; Pecher G; Metzgar RS; Finn OJ
    Cancer Res; 1994 Jun; 54(11):2856-60. PubMed ID: 7514493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloning and characterization of mouse intestinal MUC3 mucin: 3' sequence contains epidermal-growth-factor-like domains.
    Shekels LL; Hunninghake DA; Tisdale AS; Gipson IK; Kieliszewski M; Kozak CA; Ho SB
    Biochem J; 1998 Mar; 330 ( Pt 3)(Pt 3):1301-8. PubMed ID: 9494100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of new pancreatic cancer-reactive monoclonal antibodies directed against purified mucin.
    Ho JJ; Bi N; Yan PS; Yuan M; Norton KA; Kim YS
    Cancer Res; 1991 Jan; 51(1):372-80. PubMed ID: 1703039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different modes of sialyl-Tn expression during malignant transformation of human colonic mucosa.
    Ogata S; Koganty R; Reddish M; Longenecker BM; Chen A; Perez C; Itzkowitz SH
    Glycoconj J; 1998 Jan; 15(1):29-35. PubMed ID: 9530954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered mucin core peptide immunoreactivity in the colon polyp-carcinoma sequence.
    Ho SB; Ewing SL; Montgomery CK; Kim YS
    Oncol Res; 1996; 8(2):53-61. PubMed ID: 8859775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunodetection of epithelial mucin (MUC1, MUC3) and mucin-associated glycotopes (TF, Tn, and sialosyl-Tn) in benign and malignant lesions of colonic epithelium: apolar localization corresponds to malignant transformation.
    Cao Y; Schlag PM; Karsten U
    Virchows Arch; 1997 Sep; 431(3):159-66. PubMed ID: 9334836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactivity of anti-human milk fat globule antibodies with synthetic peptides.
    Xing PX; Tjandra JJ; Reynolds K; McLaughlin PJ; Purcell DF; McKenzie IF
    J Immunol; 1989 May; 142(10):3503-9. PubMed ID: 2715633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel gastric-cancer-associated mucin antigen defined by a monoclonal antibody A3D4.
    Akashi H; Hinoda Y; Itoh F; Adachi M; Endo T; Imai K
    Int J Cancer; 1997 Dec; 73(6):795-801. PubMed ID: 9399654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of rodent intestinal mucin Muc3 and alterations in a mouse model of human cystic fibrosis.
    Khatri IA; Ho C; Specian RD; Forstner JF
    Am J Physiol Gastrointest Liver Physiol; 2001 Jun; 280(6):G1321-30. PubMed ID: 11352827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of the MUC2 apomucin tandem repeat with a mouse monoclonal antibody.
    Gambús G; de Bolós C; Andreu D; Francí C; Egea G; Real FX
    Gastroenterology; 1993 Jan; 104(1):93-102. PubMed ID: 7678241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies reactive with the breast carcinoma-associated mucin core protein repeat sequence peptide also recognise the ovarian carcinoma-associated sebaceous gland antigen.
    Layton GT; Devine PL; Warren JA; Birrell G; Xing PX; Ward BG; McKenzie IF
    Tumour Biol; 1990; 11(5):274-86. PubMed ID: 1697426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibody recognizing a core epitope on mucin.
    Devine PL; Quin RJ; Shield PW; Liew YW; Sheehan JK; Thornton DJ
    Dis Markers; 1998 Oct; 14(2):99-112. PubMed ID: 9868597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.